How Does Fish Oil Help Joints?
OmegaBrite© fish oil can positively impact your Joint Mobility by reducing inflammation in cases of arthritis among others. Taking fish oil for joint pain and joint stiffness is one strategy you can implement into your daily pain management routine.
Fish Oil for Joint Pain and Mobility
Studies have shown that fish oil benefits joint health and mobility. OmegaBrite has high omega-3 EPA which provides the body with powerful balance increasing mobility, joint health, and joint comfort.
Does Fish Oil Help Joints?
People feel the OmegaBrite difference, moving more freely, with comfort and ease. In several studies, omega-3s fish oils have shown to help promote joint mobility and east joint pain.
In our testimonials read about the comfort and freedom people have found with OmegaBrite fish oil.
Receive a 10% discount with AutoRefill
We are very grateful for the change
Huge change in my son who was diagnosed bipolar. He takes no other medications at all, and is completely functional and focused. We are very grateful for the change. Your product is a godsend. Thank you!
Fish Oil Eases Depression, Adding Supplement to Drug Therapy Reduces Symptoms, By Jennifer Warner Reviewed By Michael Smith, MD WebMD Medical News, Oct. 18, 2002
ImmuneSupport.com, 10-23-2002, Authors: Malcolm Peet, MB, ChB, FRCPsych; David F. Horrobin, DPhil, BM, BCh Arch Gen Psychiatry. 2002;59:913-919
Stevens LJ, Zentall SS, Abate ML, Kuczek T, Burgess JR; Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav, Volume 59 o Issue 4-5.
Peet, M. (2003). “Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results.” Prostaglandins Leukot Essent Fatty Acids 69(6): 477-85.
Omega-3 Fats and Autism, Copyright 2000 Harcourt Publishers Ltd., Vancassel S, Durand G, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, Andres C, Chalon, S. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids. 2001 Jul;65(1):1-7.
EPA-based antidepressant in two years, Copyright – Unless otherwise stated all contents of this web site are © 2000/2002– NutraIngredients– All Rights Reserved.
“Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease”, Authors: Martha Clare Morris, ScD; Denis A. Evans, MD; Julia L. Bienias, ScD; Christine C. Tangney, PhD; David A. Bennett, MD; Robert S. Wilson, PhD; Neelum Aggarwal, MD; Julie Schneider, MD, Source: Arch Neurol. 2003;60:940-946.
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1493-9., The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: An open-label pilot study., Sivrioglu EY, Kirli S, Sipahioglu D, Gursoy B, Sarandl E., Uludag University Medical Faculty Department of Psychiatry, 16059 Gorukle, Bursa, Turkey.
Eur Neuropsychopharmacol. 2007 May-Jun;17(6-7):440-7., Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial., Wozniak J, Biederman J, Mick E, Waxmonsky J, Hantsoo L, Best C, Cluette-Brown JE, Laposata M., Pediatric Psychopharmacology Research Unit, Massachusetts General Hospital, Boston, MA 02138, USA. email@example.com
Research Indicates EPA Successfully Treats Depression
J Clin Psychiatry. 2007 Jul;68(7):1056-61., A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids., Lin PY, Su KP., Department of Psychiatry, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Psychosom Med. 2007 Dec;69(9):932-4. Epub 2007 Nov 8., High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism., Conklin SM, Manuck SB, Yao JK, Flory JD, Hibbeln JR, Muldoon MF., Department of Psychology, Allegheny College, 520 North Main Street, Meadville, PA 16335-3902, USA. Sarah.Conklin@allegheny.edu
Expert Opin Investig Drugs. 2007 Oct;16(10):1627-38., Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations., Song C, Zhao S., University of Prince Edward Island, Department of Biomedical Sciences, AVC, 550 University Avenue, Charlottetown, PE, Canada. firstname.lastname@example.org
Aust N Z J Psychiatry. 2008 Mar;42(3):192-8., Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder., Jazayeri S, Tehrani-Doost M, Keshavarz SA, Hosseini M, Djazayery A, Amini H, Jalali M, Peet M., Roozbeh Psychiatry Hospital, Department of Psychiatry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression, Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ, Department of Psychiatry, University of Arizona College of Medicine, Tucson, AZ 85724-5002, USA. email@example.com
Int Rev Psychiatry. 2006 Apr;18(2):155-72., Omega-3 fatty acids in ADHD and related neurodevelopmental disorders., Richardson AJ., Department of Physiology, Human Anatomy and Genetics, University of Oxford, UK. firstname.lastname@example.org
Am J Psychiatry. 2006 Jun;163(6):969-78., Omega-3 fatty acids and mood disorders., Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D., School of Psychiatry, University of New South Wales, and Black Dog Institute, Prince of Wales Hospital, Sydney, NSW 2031, Australia. email@example.com
Prev Med. 2006 Jan;42(1):4-13., Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique., Sontrop J, Campbell MK., Department of Epidemiology and Biostatistics, Kresge Bldg., K201, The University of Western Ontario, London, Ontario, Canada N6A 5C1. firstname.lastname@example.org
Am J Psychiatry. 2006 Jun;163(6):1098-100., Omega-3 treatment of childhood depression: a controlled, double-blind pilot study., Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH., Faculty of Health Sciences, Ben Gurion University of the Negev, Israel.
Br J Psychiatry. 2007 Feb;190:118-22., Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial., Hallahan B, Hibbeln JR, Davis JM, Garland MR., Department of Psychiatry, Beaumont Hospital and The Royal College of Surgeons in Ireland, Ireland.
Durham Research – “Using Fatty Acids for Learning Conditions”, © The Durham Local Education Authority. All rights reserved. Jan. 2004